Full text loading...
- ISSN: 1872-2113
- E-ISSN: 2212-4039
-
Stem Cell Technologies Based on Hemangioblast Technology Focusing on Human Blood Cells
- Source: Recent Patents on Drug Delivery & Formulation, Volume 7, Issue 1, Apr 2013, p. 4 - 8
-
- 01 Apr 2013
Abstract
The in vitro generation of hematopoietic stem cells (HSCs) and mature hematopoietic cells from hemangioblast derived from embryonic stem (ES) or induced pluripotent stem (iPS) cells promises to provide an alternative source of cells that could replace total bone marrow cells or HSC-enriched fractions. This mini-review deals with innovation related to hemangioblast-based methods for blood cells production as disclosed in recent patent literature and current barriers to clinical translation are discussed.
© Bentham Science Publishers